Novartis Typhoid Vaccine Seeks Partner After Securing Clinical Trial Site

Phase II study is ongoing in Pakistan, a year after Novartis convinced the Pakistani government to lift its ban on clinical trials. Antimalarials with a different mechanism of action than Coartem are in Phase I and II trials.